Results 131 to 140 of about 9,371 (163)

Statistical issues in bioequivalence [correction of bioequivalance].

Statistics in medicine, 2001
There has been much work recently on individual bioequivalence and the topic has attracted considerable controversy. Some previous controversies regarding average bioequivalence are examined. It is argued that a contributory factor in these controversies may have been confusion over the purpose of bioequivalence trials.
openaire   +1 more source

Bioavailability and Bioequivalence

The Journal of Clinical Pharmacology, 1976
openaire   +2 more sources

Bioequivalence

2021
openaire   +1 more source

Extension to the use of tolerance intervals for the assessment of individual bioequivalence

Journal of Biopharmaceutical Statistics, 1994

exaly  

Bioavailability and bioequivalence in drug development

Wiley Interdisciplinary Reviews: Computational Statistics, 2014
Shein-Chung Chow
exaly  

Prediction of fasted and fed bioequivalence for immediate release drug products using physiologically based biopharmaceutics modeling (PBBM)

European Journal of Pharmaceutical Sciences, 2020
Rebeka Jereb, Albin Kristl, Amitava Mitra   +2 more
exaly  

Evaluation of Bioequivalence for Highly Variable Drugs with Scaled Average Bioequivalence

Clinical Pharmacokinetics, 2012
László Endrenyi, László Tothfalusi, Tothfalusi László   +2 more
exaly  

Bioequivalence

2011
Graham Lockwood, Robert Kringle
openaire   +1 more source

On the assessment of variability in bioavailability/bioequivalence studies

Communications in Statistics - Theory and Methods, 1992
Shein-Chung Chow, Jen-Pei Liu
exaly  

Generic products of antiepileptic drugs: A perspective on bioequivalence and interchangeability

Epilepsia, 2010
Meir BIALER
exaly